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From the moment an RNA is transcribed, its fate largely 
depends on its interactions with RNA-binding proteins 
(RBPs). RBPs can recognize short sequence motifs (Nova, 
TDP-43, U2AF65), secondary structures (Staufen-1, 
DGCR8), post-transcriptional modifications (eIF4E, 
CBP20), RNA duplexes (AGO1-4, helicases), or bind in-
dis criminately along transcripts (FUS, helicases). 
Collectively this dynamic interplay with multiple RBPs in 
an mRNA’s life cycle helps determine the function and 
metabolism of an mRNA within a cell. Further, genotypic 
variations in many of these RBPs are responsible for 
diseases including fragile X syndrome, neurologic 
disorders and certain forms of cancer [1]. Collectively it 
makes studying RBP-RNA interactions essential due to 
the implications in both health and disease.
Here we discuss two recent studies from the labora-
tories of Matthias Hentze [2] and Markus Landthaler [3], 
which have now globally captured and defined the RBPs 
bound to mRNAs within cultured human cells. Both 
identify an unexpected wealth of RBPs, many of which 
were not previously known to interact with RNA, and 
greatly expand our understanding of the mRNA 
interactome.
Catching the interactome
Experimental studies on RBP-RNA interactions have 
typically employed top-down approaches such as RNA 
immunoprecipitation, UV cross-linked immunopreci pi-
ta tion (CLIP) [4] and photoactivatable ribonucleoside 
(PAR)-CLIP [5] to study RNA interactions of individual 
RBPs, using the protein as the bait in enrichment steps. 
More recently, others have reversed this approach and 
cast a tagged RNA as the bait in order to identify proteins 
interacting with it [6]. In an attempt to identify all 
proteins interacting with a pool of RNA, in vitro studies 
have incubated protein microarrays with labeled RNA, 
and identified a number of enzymes as unexpected RNA 
binders [7,8]. However, such in vitro studies could miss 
many context-dependent interactions that are present in 
physiological settings.
e two recent studies from the Hentze and Landthaler 
laboratories have taken the RNA bait concept a step 
further by capturing proteins by covalent cross-linking to 
polyadenylated RNA, mainly corresponding to mRNAs, 
and thereby generated a global mRNA interactome in 
HeLa [2] or HEK-293 [3] cell culture systems. In both 
studies, RNA-binding proteins are physically cross-linked 
to mRNAs using 254 nM UV-C light [2] or 365 nM UV in 
conjunction with PARs [2,3]. Next, cellular mRNA and 
the bound interactome are efficiently captured with 
oligo-dT-coated beads and purified under stringent con-
ditions to eliminate contamination from non-cross-
linked proteins, including those deriving from non-cross-
linked protein-protein interactions. Finally, proteins are 
released by RNAse digestion, gel resolved and analyzed 
by quantitative mass spectrometry (MS) approaches to 
reveal the protein interactome of the cellular mRNAs 
(Figure 1a).
Landthaler and colleagues used SILAC-based MS, 
where the control non-cross-linked sample is grown in 
the presence of amino acids with heavy isotopes, 
generating quantitative MS data of cross-linked versus 
non-cross-linked proteins. ereby, they could exclude 
135 proteins that appeared as contaminants based on a 
label-swap experiment, and they identified 797 proteins 
that are high-confidence RNA-binders [3]. Hentze and 
colleagues compiled an mRNA interactome of 860 
proteins with a false discovery rate of less than 0.01 based 
on spectral count and peptide ion count of identified 
proteins [2]. Both studies validated their data set by 
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Figure 1. Identication of the mRNA interactome. RNA-binding proteins are covalently cross-linked to RNAs using 254 nM UV-C light [2] or 365 
nM UV light in conjunction with photoactivatable ribonucleosides (PARs) such as 4-thiouridine (4SU) [2,3]. The RNA is used as bait in a pull-down 
with oligo-dT-coated beads and puried under stringent conditions to eliminate contamination from non-cross-linked proteins. (a) Proteins are 
released by RNAse digestion and analyzed by mass spectrometry. (b) RNAs are blotted onto nitrocellulose, released by proteinase K, and analyzed 
with high-throughput sequencing. The diagnostic T to C changes in 4SU-labelled RNA identies cross-link sites. PAR-CLIP, photoactivatable 
ribonucleoside UV cross-linked immunoprecipitation; X-link, cross-link.
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testing around 20 candidates for RNA binding after 
immunoprecipitation, achieving a greater than 80% vali-
da tion rate. However, only one study tested candi dates 
for direct protein-RNA interaction using a gel imaging 
system [3], and only nine identified proteins have had 
their bound mRNAs experimentally probed with high-
throughput sequencing [2,3]. It therefore remains un-
known how many of the newly identified RBPs bind RNA 
with sequence specificity, and which are non-sequence-
specific binders. Moreover, it remains possible that some 
of the identified proteins strongly interact with other 
RBPs and thereby elude the stringent wash steps, but do 
not directly cross-link to RNA.
Caught on the line
With the stringent filtering criteria, both groups found 
that 800 to 850 RBPs were confidently enriched in 
captured fractions, representing roughly 15% of cellular 
proteins [2]. Interestingly, a slightly larger number of 
RBPs were identified when using UV-C compared with 
PAR cross-linking [2]. The approach purified poly-A-
containing transcripts, and therefore proteins binding to 
intronic RNA and other non-polyadenylated RNAs may 
not be identified. Thus, the interactome is a conservative 
estimate of the total number of RBPs.
The main surprise was that both datasets yielded many 
previously unannotated RBPs with no RNA-related Gene 
Ontology (GO) classifications, homology to known RBPs 
or experimental validations (315 [2] versus 245 [3]). 
Several were DNA-binding factors, others were kinases, 
while 17 metabolic enzymes were confidently identified 
as RBPs by Hentze and colleagues [2], 4 of which were 
confirmed in the other study [3].
the range of proteins on the rBP market
The authors analyzed the enrichment of GO annotations, 
known RNA-binding domains and other structural 
domains in the interactome, giving further insight into 
their catch. First, they found that all previously known 
RNA-binding domains were present within the mRNA 
interactome, constituting half [2] of all mRNA-bound 
proteins. Among the previously unknown RBPs, Hentze 
and colleagues identified proteins with the SAP and 
basic-amino-acid-rich WD40 domains, both of which are 
known to commonly bind DNA but have isolated family 
members that have previously been reported to bind 
RNA. This was complemented with other enriched 
motifs with no previous confirmation of RNA-binding 
ability such as AKAP95 and HC5HC2H subtypes of Znf 
domains, and the RAP and FASTK domains present in 
the family of fas-activated serine/threonine kinases. 
Encouragingly, overlap of some of these domains was 
seen in the interactome of the other study (Table 1) [3]. 
This greatly expands the repertoire of RNA-binding 
domains and will direct new homology searches for other 
candidate RBPs across evolution.
Second, Landthaler and colleagues report another 
intri guing observation. Using their dataset to generate a 
protein-protein interaction network, they found a 
remarkable enrichment for the GO terms ‘DNA damage’ 
and ‘transcription’, which are almost as enriched as RNA-
related processes. Seventeen proteins with the GO anno-
tation ‘response to DNA damage’ are part of the inter-
actome. Three members are annotated as RBPs and the 
authors found that three others have been previously 
recognized to bind to a specific RNA. It will be interesting 
to determine if these RBPs bind RNA as part of the DNA 
damage response, perhaps as part of transcription-
coupled repair or as effectors for the small RNA double-
stranded break markers, or alternatively if their RNA-
binding property is used for other processes.
Third, Hentze and colleagues observed that RBPs are 
remarkably enriched in disordered regions. For approxi-
mately 50% of all the mRNA-interacting proteins, more 
than 40% of their residues are predicted to be in a dis-
ordered state [2]. Why are RNA-binding proteins 
enriched in disordered regions? Partially, the authors 
explain this occurrence by the fact that SR and RGG 
boxes are disordered regions that are known to bind RNA 
and are present in classical RNA-binding proteins. 
table 1. Overview of protein domains that are enriched 
among proteins not previously known to bind rNA
    Domain 
                                   Identified in study led by: previously 
Putative non-classical   described to  
RNA-binding domain Hentze [2] Landthaler [3] bind RNA
AlbA-like DNA binding  ✔ Yes
CBF  ✔  No
DZF   ✔ No
FAST and RAP ✔ ✔* No
HAT helix  ✔ No
HMG box ✔¶ ✔ Yes
MMR HSR1 ✔  No
PAP associated ✔ ✔* No
polyK-patches ✔  No
SAP  ✔ ✔ Yes
SWAP/SURP  ✔ Yes
WD40 ✔  Yes
‘Winged helix’ DNA binding  ✔ No
YGG boxes ✔  No
ZNF motif
 Subtype AKAP95 ✔ ✔* No
 Subtype HC5HC2H ✔  No
*Corrected P‑value >0.05; ¶P‑value >0.1.
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Disordered domains are able to adopt multiple inter-
acting structures, thereby providing flexibility in binding 
to multiple proteins but also to nucleic acids, particularly 
RNA. The dynamic nature of folded and unfolded RNA 
states enables induced-fit interactions between RNA and 
flexible protein domains [9]. Yet another explanation is 
offered by the recent observation that low-complexity 
domains (which are predicted to be disordered) form 
granules in vitro, which might resemble intracellular 
RNA granules [10]. In this case, the overwhelming 
percentage of RBPs with unstructured domains would 
hint at the functional importance of diverse RNA 
granules.
Kinks in the line
Landthaler and colleagues further examined the binding 
sites of the interactome on the mRNAs. To do this, the 
oligo-dT purified, PAR-labeled RNAs were partially 
RNase digested around cross-link sites, cleared of 
unbound RNA, and then proteinase digested in order to 
release cross-linked RNAs that were adapted for high-
throughput sequencing. Evaluating locations of T→C 
transitions in sequence tags that occur at or near cross-
link sites when using PARs allows identification of 
protein-binding sites on mRNAs with near nucleotide 
resolution (Figure 1b) [5]. Specifically, the analysis focused 
on cross-links in the 3’ UTRs, where RBP-binding sites 
can be distinguished from those of the translating ribo-
somes. With 28% of all 3’ UTR T nucleotides converted 
to C nucleotides, the approach convincingly demon-
strates widespread binding of RBPs across this region of 
the mRNA [3]. Further, an enhanced evolutionary con-
ser vation surrounding these sites implies selective 
pressure to maintain many of these interactions across 
multiple species.
re-casting for another catch
The major challenge following these reports will be the 
functional validation of all identified RBPs and putative 
RNA-binding domains, including the 86 interactome 
RBPs associated with human Mendelian diseases [1]. 
Further, it is expected that applying interactome capture 
to model organisms and specific biological paradigms 
will continue to be fruitful. Significant remodeling of 
protein-RNA interactions is expected under conditions 
of hypoxia, during the cell cycle, after drug treatment or 
knockdown of important proteins, among others. Alter-
na tively, interactome capture across samples from 
multiple species would identify stages in evolution where 
new RNA-binding capabilities emerged. Understanding 
the re-modeling of the mRNA interactome will therefore 
provide great insight into the dynamic interplay of RNAs 
and RBPs during an mRNA life cycle.
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